Ixazomib citrate EtOH, CAS [[2026591-78-4]]

Produktübersicht

• Artikelname: Ixazomib citrate EtOH, CAS [[2026591-78-4]]
• Artikelnummer: TGM-T69983
• Hersteller Artikelnummer: T69983
• Alternativnummer: TGM-T69983-25MG,TGM-T69983-50MG,TGM-T69983-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Ixazomib citrate, also known as MLN9708, is a prodrug of Ixazomib (MMLN-2238). MLN9708 is an orally bioavailable second generation proteasome inhibitor (PI) with potential antineoplastic activity. MLN9708, after hydrolyzing to pharmacologically active MLN2238 (ixazomib), is a next-generation proteasome inhibitor with demonstrated preclinical and clinical antimyeloma activity. MLN9708, compared with bortezomib, has improved pharmacokinetics, pharmacodynamics, and antitumor activity in preclinical studies.

Produkteigenschaften

• Molekulargewicht: 563.188
• CAS Nummer: [2026591-78-4]
• Formel: C22H29BCl2N2O10
• Target-Kategorie: Others

Bilder

T69983